Compare Stocks: FSNUY, MDT, BSX, and EW

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$50.39 +2.1%	$46.34	$42.20 ▼ $109.50	$71.55B	0.56	20.35 million shs	35.99 million shs
EW Edwards Lifesciences	$89.89 +0.1%	$89.21	$72.30 ▼ $96.29	$51.72B	0.85	4.00 million shs	2.82 million shs
FSNUY Fresenius SE & Co.	$13.64 +0.0%	$12.44	$10.33 ▼ $33.93	$30.72B	0.61	224,436 shs	60,532 shs
MDT Medtronic	$93.44 +1.2%	$84.39	$73.31 ▼ $106.33	$118.14B	0.55	7.00 million shs	7.49 million shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	+1.86%	-2.66%	+17.17%	-12.69%	-52.42%
EW Edwards Lifesciences	-0.14%	-1.77%	+6.53%	+4.61%	+10.60%
FSNUY Fresenius SE & Co.	+0.04%	-0.43%	+9.47%	+19.96%	-1.15%
MDT Medtronic	+1.07%	+2.56%	+13.95%	+18.79%	+0.33%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$50.39 +2.1%	$46.34	$42.20 ▼ $109.50	$71.55B	0.56	20.35 million shs	35.99 million shs
EW Edwards Lifesciences	$89.89 +0.1%	$89.21	$72.30 ▼ $96.29	$51.72B	0.85	4.00 million shs	2.82 million shs
FSNUY Fresenius SE & Co.	$13.64 +0.0%	$12.44	$10.33 ▼ $33.93	$30.72B	0.61	224,436 shs	60,532 shs
MDT Medtronic	$93.44 +1.2%	$84.39	$73.31 ▼ $106.33	$118.14B	0.55	7.00 million shs	7.49 million shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	+1.86%	-2.66%	+17.17%	-12.69%	-52.42%
EW Edwards Lifesciences	-0.14%	-1.77%	+6.53%	+4.61%	+10.60%
FSNUY Fresenius SE & Co.	+0.04%	-0.43%	+9.47%	+19.96%	-1.15%
MDT Medtronic	+1.07%	+2.56%	+13.95%	+18.79%	+0.33%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	2.71	Moderate Buy	$71.62	42.12% Upside
EW Edwards Lifesciences	2.74	Moderate Buy	$100.27	11.55% Upside
FSNUY Fresenius SE & Co.	3.00	Buy	N/A	N/A
MDT Medtronic	2.67	Moderate Buy	$98.83	5.77% Upside

Current Analyst Ratings Breakdown

Latest FSNUY, MDT, BSX, and EW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2026	MDT Medtronic	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
8/18/2026	MDT Medtronic	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$91.00
8/10/2026	MDT Medtronic	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
8/6/2026	FSNUY Fresenius SE & Co.	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/31/2026	BSX Boston Scientific	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
7/30/2026	BSX Boston Scientific	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$85.00 ➝ $70.00
7/30/2026	BSX Boston Scientific	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$74.00 ➝ $67.00
7/30/2026	BSX Boston Scientific	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$60.00
7/30/2026	BSX Boston Scientific	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$56.00
7/30/2026	BSX Boston Scientific	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$70.00 ➝ $66.00
7/30/2026	BSX Boston Scientific	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Equal Weight	$55.00 ➝ $50.00

(Data available from 8/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$20.07B	3.64	$4.12 per share	12.23	$17.37 per share	2.90
EW Edwards Lifesciences	$6.07B	8.53	$2.85 per share	31.50	$18.63 per share	4.83
FSNUY Fresenius SE & Co.	$25.87B	1.19	$1.56 per share	8.72	$9.93 per share	1.37
MDT Medtronic	$36.36B	3.29	$7.95 per share	11.76	$39.00 per share	2.40

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$2.90B	$2.47	20.40	14.73	1.08	17.50%	19.28%	10.89%	10/28/2026 (Estimated)
EW Edwards Lifesciences	$1.07B	$1.74	51.66	26.59	2.26	15.43%	15.68%	12.05%	10/29/2026 (Estimated)
FSNUY Fresenius SE & Co.	$1.43B	$0.79	17.27	11.86	N/A	6.67%	10.33%	4.87%	11/4/2026 (Estimated)
MDT Medtronic	$4.80B	$3.73	25.05	14.65	2.47	13.20%	14.51%	7.76%	9/1/2026 (Estimated)

Latest FSNUY, MDT, BSX, and EW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/1/2026	Q1 2027	MDT Medtronic	$1.39	N/A	N/A	N/A	$9.55 billion	N/A
8/5/2026	Q2 2026	FSNUY Fresenius SE & Co.	$0.25	$0.24	-$0.01	$0.20	$6.65 billion	$6.91 billion
7/29/2026	Q2 2026	BSX Boston Scientific	$0.83	$0.86	+$0.03	$0.61	$5.38 billion	$5.44 billion
7/23/2026	Q2 2026	EW Edwards Lifesciences	$0.7430	$0.78	+$0.0370	$0.42	$1.70 billion	$1.74 billion
6/3/2026	Q4 2026	MDT Medtronic	$1.54	$1.55	+$0.01	$0.96	$9.62 billion	$9.81 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
FSNUY Fresenius SE & Co.	$0.20	1.47%	N/A	25.32%	N/A
MDT Medtronic	$2.88	3.08%	+4.13%	77.21%	49 Years

Latest FSNUY, MDT, BSX, and EW Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/20/2026	MDT Medtronic	quarterly	$0.72	3.12%	9/25/2026	9/25/2026	10/16/2026
6/3/2026	MDT Medtronic	quarterly	$0.72	3.56%	6/26/2026	6/26/2026	7/17/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.43	1.24	0.74
EW Edwards Lifesciences	0.06	4.52	3.77
FSNUY Fresenius SE & Co.	0.41	1.27	0.98
MDT Medtronic	0.52	2.13	1.62

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
EW Edwards Lifesciences	79.46%
FSNUY Fresenius SE & Co.	N/A
MDT Medtronic	82.06%

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.34%
EW Edwards Lifesciences	0.31%
FSNUY Fresenius SE & Co.	N/A
MDT Medtronic	0.26%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	59,000	1.45 billion	1.44 billion	Optionable
EW Edwards Lifesciences	16,000	575.80 million	574.02 million	Optionable
FSNUY Fresenius SE & Co.	178,394	2.25 billion	N/A	Not Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable

FSNUY, MDT, BSX, and EW Headlines

Recent News About These Companies

Madison Asset Management LLC Makes New Investment in Medtronic PLC $MDT

August 22 at 5:28 AM | marketbeat.com

Medtronic PLC $MDT Shares Purchased by K.J. Harrison & Partners Inc

August 22 at 5:11 AM | marketbeat.com

Flossbach Von Storch SE Makes New Investment in Medtronic PLC $MDT

August 22 at 4:02 AM | marketbeat.com

Medtronic PLC $MDT Shares Bought by First National Bank of Omaha

August 22 at 3:53 AM | marketbeat.com

Medtronic PLC $MDT Holdings Increased by Equity Investment Corp

August 22 at 3:53 AM | marketbeat.com

Alpine Woods Capital Investors LLC Takes $5.36 Million Position in Medtronic PLC $MDT

August 22 at 3:06 AM | marketbeat.com

Medtronic: The CAS Catalyst Can Close A 27% Peer Discount

August 21 at 10:30 PM | seekingalpha.com

Medtronic PLC (NYSE:MDT) Announces $0.72 Quarterly Dividend

August 21 at 8:49 AM | marketbeat.com

34,434 Shares in Medtronic PLC $MDT Acquired by Trust Co. of Vermont

August 21 at 5:12 AM | marketbeat.com

Medtronic PLC $MDT Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd.

August 21 at 5:04 AM | marketbeat.com

Medtronic PLC $MDT Shares Bought by Longfellow Investment Management Co. LLC

August 21 at 5:03 AM | marketbeat.com

Medtronic PLC $MDT Stock Holdings Increased by OneDigital Investment Advisors LLC

August 21 at 5:03 AM | marketbeat.com

Tulsa Wealth Advisors INC Has $945,000 Stake in Medtronic PLC $MDT

August 21 at 5:03 AM | marketbeat.com

Nippon Life Global Investors Americas Inc. Sells 15,800 Shares of Medtronic PLC $MDT

August 21 at 5:03 AM | marketbeat.com

Diamond Hill Capital Management LLC Investment Advisor Has $131.75 Million Holdings in Medtronic PLC $MDT

August 21 at 3:52 AM | marketbeat.com

Deutsche Bank AG Trims Holdings in Medtronic PLC $MDT

August 21 at 3:51 AM | marketbeat.com

Continuum Advisory LLC Reduces Position in Medtronic PLC $MDT

August 21 at 3:51 AM | marketbeat.com

Medtronic PLC $MDT Shares Sold by Flputnam Investment Management Co.

August 21 at 3:51 AM | marketbeat.com

Global Retirement Partners LLC Invests $4.62 Million in Medtronic PLC $MDT

August 21 at 3:44 AM | marketbeat.com

BlackRock Inc. Acquires 838,220 Shares of Medtronic PLC $MDT

August 21 at 3:21 AM | marketbeat.com

Medtronic PLC $MDT Shares Sold by Bank of New York Mellon Corp

August 21 at 3:12 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FSNUY, MDT, BSX, and EW Company Descriptions

Boston Scientific NYSE:BSX

$50.39 +1.02 (+2.07%)

As of 08/21/2026 03:58 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Edwards Lifesciences NYSE:EW

$89.89 +0.06 (+0.07%)

As of 08/21/2026 03:58 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Fresenius SE & Co. OTCMKTS:FSNUY

$13.64 +0.01 (+0.04%)

As of 08/21/2026 03:58 PM Eastern

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Medtronic NYSE:MDT

$93.44 +1.14 (+1.24%)

As of 08/21/2026 03:58 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FSNUY, MDT, BSX, and EW Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FSNUY, MDT, BSX, and EW Earnings

Compare Dividends

Latest FSNUY, MDT, BSX, and EW Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FSNUY, MDT, BSX, and EW Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FSNUY, MDT, BSX, and EW Company Descriptions

Boston Scientific NYSE:BSX

Edwards Lifesciences NYSE:EW

Fresenius SE & Co. OTCMKTS:FSNUY

Medtronic NYSE:MDT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FSNUY, MDT, BSX, and EW Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FSNUY, MDT, BSX, and EW Earnings

Compare Dividends

Latest FSNUY, MDT, BSX, and EW Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FSNUY, MDT, BSX, and EW Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FSNUY, MDT, BSX, and EW Company Descriptions

Boston Scientific NYSE:BSX

Edwards Lifesciences NYSE:EW

Fresenius SE & Co. OTCMKTS:FSNUY

Medtronic NYSE:MDT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools